Research progress of clinical study on cerebrovascular disease

Abstract

During the period of Twelfth Five-Year Plan for National Economic and Social Development, clinical study on cerebrovascular disease in China has made great progress. The results of antiplatelet treatment in patients with high-risk non-disabling cerebrovascular events, standardized secondary prevention of ischemic stroke, epidemiological survey of asymptomatic ischemic stroke in community population, cross-sectional survey on traditional Chinese medicine for treating ischemic stroke, the impact of blood glucose on prognosis of acute ischemic stroke, ischemic stroke combined with chronic kidney disease and cerebral microbleeds, biomarkers of ischemic cerebrovascular diseases, mitochondrial encephalomyopathy with lactic academia and stroke-like episodes (MELAS) and encephalatrophy, perioperative management of blood pressure in intracerebral hemorrhage, vascular structural abnormality-related intracerebral hemorrhage score (VSARICHS), and epidemiological survey of cerebrovascular disease in China have been published in many important journals. This paper reviewed these studies and made a brief introduction.

DOI: 10.3969/j.issn.1672-6731.2018.02.003